SYNBIOTIC SE (SBX.DE) Stock Price & Overview
FRA:SBX • DE000A3E5A59
The current stock price of SBX.DE is 2.265 EUR. Today SBX.DE is down by -2.16%. In the past month the price increased by 9.41%. In the past year, price decreased by -34.32%.
SBX.DE Key Statistics
- Market Cap
- 17.35M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
SBX.DE Stock Performance
SBX.DE Stock Chart
SBX.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SBX.DE. When comparing the yearly performance of all stocks, SBX.DE turns out to be only a medium performer in the overall market: it outperformed 48.26% of all stocks.
SBX.DE Earnings
SBX.DE Forecast & Estimates
6 analysts have analysed SBX.DE and the average price target is 6.17 EUR. This implies a price increase of 172.45% is expected in the next year compared to the current price of 2.265.
SBX.DE Groups
Sector & Classification
SBX.DE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SBX.DE Ownership
SBX.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.03 | 184.165B | ||
| SNW | SANOFI | 9.03 | 183.755B | ||
| 1SAN | SANOFI | 9.02 | 183.392B | ||
| UCB | UCB SA | 24.56 | 49.367B | ||
| UNC | UCB SA | 24.6 | 49.308B | ||
| MRK | MERCK KGAA | 13.24 | 48.261B | ||
| 1MRK | MERCK KGAA | 12.9 | 48.217B | ||
| BAYN | BAYER AG-REG | 8.36 | 39.311B | ||
| 1BAYN | BAYER AG-REG | 8.36 | 39.311B | ||
| IPN | IPSEN | 12.56 | 13.091B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.681B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.24 | 9.666B | ||
| VIRP | VIRBAC SA | 15.53 | 2.844B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About SBX.DE
Company Profile
SynBiotic SE operates as a cannabis company, which engages in the research and development of cannabinoid and terpene-based solutions. The company is headquartered in Muenchen, Bayern and currently employs 79 full-time employees. The company went IPO on 2021-05-13. The firm operates in the industrial hemp and cannabis market. The company invests in ventures across the value chain from cultivation and research to development (R&D), production, sales, and distribution of cannabinoid-based products. This includes pharmaceuticals, cosmetics, nutrition and supplements as well as lifestyle products. Its main focus is in the development of medical cannabis and industrial hemp markets. Medical cannabis is used for therapeutic applications with patients. Industrial hemp is used to manufacture products such as fibres, seeds, stalks, shives, and oils across various industries. The firm's major brands include Hempamed, The Hempany, Hempamed Rx among others.
Company Info
IPO: 2021-05-13
SYNBIOTIC SE
Muensterstrasse 336
Muenchen BAYERN DE
Employees: 55
SYNBIOTIC SE / SBX.DE FAQ
Can you describe the business of SYNBIOTIC SE?
SynBiotic SE operates as a cannabis company, which engages in the research and development of cannabinoid and terpene-based solutions. The company is headquartered in Muenchen, Bayern and currently employs 79 full-time employees. The company went IPO on 2021-05-13. The firm operates in the industrial hemp and cannabis market. The company invests in ventures across the value chain from cultivation and research to development (R&D), production, sales, and distribution of cannabinoid-based products. This includes pharmaceuticals, cosmetics, nutrition and supplements as well as lifestyle products. Its main focus is in the development of medical cannabis and industrial hemp markets. Medical cannabis is used for therapeutic applications with patients. Industrial hemp is used to manufacture products such as fibres, seeds, stalks, shives, and oils across various industries. The firm's major brands include Hempamed, The Hempany, Hempamed Rx among others.
What is the stock price of SYNBIOTIC SE today?
The current stock price of SBX.DE is 2.265 EUR. The price decreased by -2.16% in the last trading session.
Does SYNBIOTIC SE pay dividends?
SBX.DE does not pay a dividend.
How is the ChartMill rating for SYNBIOTIC SE?
SBX.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What sector and industry does SYNBIOTIC SE belong to?
SYNBIOTIC SE (SBX.DE) operates in the Health Care sector and the Pharmaceuticals industry.
What is SYNBIOTIC SE worth?
SYNBIOTIC SE (SBX.DE) has a market capitalization of 17.35M EUR. This makes SBX.DE a Nano Cap stock.